Dornase Alfa

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

Usefulness of DORNASE in COVID-19 on HFNO

Dornase Alfa Administered to Patients With COVID-19 (DACOVID)

Pulmozyme for Sjogren's Associated Cough

A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects

Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.

Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)

A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)

A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis

Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient

Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa